Top 7 Breakthrough Therapies Transforming Axial Spondyloarthritis Treatment According to a newly published market research report by 24LifeSciences, global axial spondyloarthritis treatment market is valued at USD 4.12 billion in 2026 and is projected to reach USD 7.05 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period. Axial spondyloarthritis (axSpA) is a chronic inflammatory arthritis primarily affecting the spine and sacroiliac joints, causing significant pain, stiffness, and potential spinal fusion. Treatment focuses on reducing inflammation, managing symptoms, and preserving mobility through pharmaceutical interventions like NSAIDs, biologic DMARDs (including TNF inhibitors and IL-17 inhibitors), and targeted synthetic DMARDs, supplemented by physiotherapy and lifestyle modifications. The growing understanding of its pathophysiology and the expansion of effective biologic treatments continue to enhance patient outcomes and drive market evolution. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9253/axial-spondyloarthritis-treatment-market

Pls avoid all these if u have ulcer: 1. Don’t smoke. 2. Don’t take alcohol. 3. Avoid soda and fizzy drinks, they can make it worse. 4. Manage stress properly. Day to day stress does not cause ulcers but it can worsen ulcer symptoms. 5. Avoid caffeine. 6. Limit beans, peppery, and spicy foods 7. Avoid drugs known as NSAIDs (eg Ibuprofen, Diclofenac, Felvin), they can worsen ulcer. If you must use them, make sure it’s prescribed by your healthcare provider and you eat before you take them.